Meridigen Biotech Co., Ltd.
6 clinical trials · Sponsor
◉ Watch Meridigen Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA). (NCT04893174) | Meridigen Biotech Co., Ltd. | 2022-09-15 |
| Mesenchymal Stem Cells for The Treatment of Frailty Syndrome (NCT04914403) | Meridigen Biotech Co., Ltd. | 2021-09-01 |
| Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease (NCT04206007) | Meridigen Biotech Co., Ltd. | 2020-06-11 |
| Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke (NCT04097652) | Meridigen Biotech Co., Ltd. | 2019-12-05 |
| Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants (NCT03631420) | Meridigen Biotech Co., Ltd. | 2018-10-26 |
Track Meridigen Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.